| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |